| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBH | CTRPv2 | pan-cancer | AAC | 0.22 | 0.08 |
| mRNA | ARG2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | LCORL | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | ZC3H4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | TSEN34 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.08 |
| mRNA | CNTNAP5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | PRAMEF15 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | PCDHB9 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | FNDC4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | YIPF4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
